
Jan 22 (Reuters) - Tiziana Life Sciences Ltd TLSA.O:
TIZIANA LIFE SCIENCES ANNOUNCES DISCOVERY OF NEW IMMUNE BIOMARKERS IN MULTIPLE SCLEROSIS PATIENTS TREATED WITH NASAL FORALUMAB
TIZIANA LIFE SCIENCES LTD - GENE EXPRESSION CHANGES DETECTED THREE MONTHS AFTER FORALUMAB DOSING
Source text: ID:nGNX6FqjN3
Further company coverage: TLSA.O
((Reuters.Briefs@thomsonreuters.com;))